Anti-Human CD279 Recombinant Antibody(Cemiplimab)

Name: Anti-Human CD279 Recombinant Antibody(Cemiplimab)
Brand: KMD Bioscience
SKU: YR1516

YR1516

科研级 Cemiplimab ( 西米普利单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Cemiplimab

DATASHEET MSDS

Product Description

Alias	科研级 Cemiplimab ( 西米普利单抗 ), Anti-CD279 Recombinant Antibody, Research Grade Cemiplimab
Catalog Number	YR1516
Molecular Name	Cemiplimab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Cemiplimab, sold under the brand name Libtayo, is a monoclonal antibody medication for the treatment of squamous cell skin cancer. Cemiplimab belongs to a class of drugs that binds to the programmed death receptor-1 (PD-1), blocking the PD-1/PD-L1 pathway.
CAS Number	1801342-60-8
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD279[Homo sapiens]

Login